Written question asked by Baroness Masham of Ilton (Crossbench) on Wednesday, 27 October 2021, in the House of Lords. It was due for an answer on Wednesday, 10 November 2021. It was answered by Lord Kamall (Conservative) on Friday, 5 November 2021 on behalf of the Department of Health and Social Care.

Medical Treatments: Life Sciences

Question: To ask Her Majesty's Government what assessment they have made of whether the changes proposed in the National Institute for Health and Care Excellence's Methods Review will help deliver on their ambition for the UK to be a global life sciences hub.

Answer: The Department supports the proposals in the National Institute for Health and Care Excellence’s (NICE) review of its methods and processes. The proposals are consistent with the expectations for the review in the Voluntary Scheme for Branded Medicines Pricing and Access, agreed with industry. NICE’s review will ensure it retains global leadership in the evaluation and appraisal of new medicines and technologies which will promote the United Kingdom as the best place in the world to develop, trial, launch and adopt innovative new medicines, improving patient access. While it is too early to comment on the final changes to NICE’s methods and processes, NICE is reviewing the responses to its latest consultation and expects to publish the final programme manual in early 2022.

Secondary information

Type: Written question
Reference: HL3498
Session: 2021-22
Grouped for answer: Yes
Subjects: Medical treatments National Institute for Health and Care Excellence Reviews Life sciences
Link: View this Written question on www.parliament.uk